High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial.
about
Prostate Radiotherapy in the Era of Advanced Imaging and Precision MedicineHigh dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancerProstate cancer: ESMO Consensus Conference Guidelines 2012The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.HDR Brachytherapy in the Management of High-Risk Prostate Cancer.Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy.Significant association of brachytherapy boost with reduced prostate cancer-specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer.Racial and socioeconomic disparities in the selection of prostate brachytherapyLow rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer.Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinomaUpdate on prostate brachytherapy: long-term outcomes and treatment-related morbidity.Clinical Outcomes of CyberKnife Radiotherapy in Prostate Cancer Patients: Short-term, Single-Center ExperienceProstate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer.Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes.Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir.Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer.Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement.The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer.Curative radiation therapy in prostate cancer.Improved tumour control probability with MRI-based prostate brachytherapy treatment planning.Early quality of life outcomes in patients with prostate cancer managed by high-dose-rate brachytherapy as monotherapy.Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy.High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients.Stereotactic body radiotherapy for prostate cancer: treatment approaches and clinical outcomes.Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.Prostate cancer high dose-rate brachytherapy: review of evidence and current perspectives.Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer.Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer
P2860
Q26749961-8FC5855B-A795-4EEA-A620-05ABBC606905Q26824608-E6A7CAA3-9D05-46B7-B915-AF956ED7F62AQ27022847-96910195-D44A-4F7C-B476-22B50B3D5138Q35166901-2897EBBB-69A9-4B23-B851-C55B76C84D6DQ35810413-E9525BBF-083C-42FC-89AA-C79BA392F40AQ36551293-E0BF45C9-8D81-4CCD-96C3-11C105D190ABQ36802277-4071A844-5599-46CB-B6E6-4CEE8AC22770Q37231596-3DAA8D82-6398-4D10-AF75-70D974A7D63BQ37348060-4E1F2485-B831-4288-B9F5-F88D9EC70C4FQ37551757-5FE92D75-9BBD-41B1-8BEA-3A25E0A63F5BQ37852580-8BF42A14-900E-4EDF-BB69-81F4E3CCD0F1Q38306112-532033A0-D070-4D82-B200-A94DE60AEA3BQ39712837-67C7EF5F-868F-4355-A547-C00A56424157Q41886788-4CC67096-93FC-4FE0-82B4-4DA4EB45DA8AQ41889550-9F5C00C0-CFDC-48B0-9C96-B01A02E87581Q41952611-24658172-3982-4435-9A31-A988F5371B33Q42045691-7099DCAA-A4C9-4182-9EE7-8F17A8B34340Q42277882-A624586C-B1FF-42CD-B3DE-AA2585C43F39Q42948029-5B502AB3-01F5-442D-BB8F-A87E73AD5C09Q44666799-AA66F721-CFA6-4EA7-8FCA-E4FB19A2EE4CQ45025743-48B81D26-6EB0-41CA-8C06-669328D6DA21Q46158562-63B6708E-EAE9-4086-A422-46CD7796A9C8Q46605415-8BD263D5-AA01-4FC8-BB01-2A75F25F65B0Q46801852-02044464-CB80-4E32-BC56-15E98A0A5F53Q47140723-F7C015ED-C1AD-48A9-92DB-39DFB4FB2FC8Q47751134-014F810F-D043-48DA-942D-AD9702A4B4D2Q48101934-DE9A3A41-306B-4B3F-906A-529BDA162965Q51614445-519E8609-72CE-4101-AA39-8659D6EB9E8BQ57860471-91579B2C-4434-4976-B23D-C38DF4CD380F
P2860
High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
High dose rate brachytherapy i ...... randomised phase three trial.
@ast
High dose rate brachytherapy i ...... randomised phase three trial.
@en
type
label
High dose rate brachytherapy i ...... randomised phase three trial.
@ast
High dose rate brachytherapy i ...... randomised phase three trial.
@en
prefLabel
High dose rate brachytherapy i ...... randomised phase three trial.
@ast
High dose rate brachytherapy i ...... randomised phase three trial.
@en
P2093
P1476
High dose rate brachytherapy i ...... randomised phase three trial.
@en
P2093
Kate Motohashi
Linda Bryant
Peter Bownes
Peter J Hoskin
Peter Ostler
P304
P356
10.1016/J.RADONC.2007.04.011
P577
2007-05-24T00:00:00Z